SANUWAVE Health Financials - Benzinga

SPY772.04+0.09%QQQ745.40+0.12%BTC/USD83,997.64−0.11%DIA517.72+0.04%GLD393.05−0.09%TLT79.38+0.08%

SANUWAVE Health Inc

SNWVNASDAQ

Trade with Public

Trade with Public

$5.04

0.193.92%

At close: Sep 25, 5:00 PM EST

$4.85

-0.19-3.77%

After Hours: Sep 25, 6:26 AM EST

Overview News Earnings Forecast Events Price TargetsFinancialsSentiment Ownership Compare Stock Report

SANUWAVE Health Financials

SANUWAVE Health (SNWV) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
SANUWAVE Health Q2 EPS $(0.08) Down From $(0.04) YoY, Sales $9.739M Down From $10.054M YoY

SANUWAVE Health (NASDAQ:SNWV) reported quarterly losses of $(0.08) per share. This is a 100 percent decrease over losses of $(0.04) per share from the same period last year. The company reported $9.739 million in sales

Benzinga Newsdesk

What's Going On With SANUWAVE Health Stock On Friday?

NASDAQ:SNWV shares are trading down 0.5% in premarket as SANUWAVE Health beats Q2 revenue expectations, but faces financial constraints and competition.

Lekha Gupta

PRO
SANUWAVE Health Raises Q2 Sales Guidance from $8.500M-$9.500M to $9.600M-$9.800M

SANUWAVE Health (NASDAQ:SNWV) raises Q2 sales outlook from $8.500 million-$9.500 million to $9.600 million-$9.800 million.

Benzinga Newsdesk

PRO
SANUWAVE Health Raises Prelim. Q2 Revenue From $8.5M-$9.5M To $9.6M-$9.8M

Benzinga Newsdesk

PRO
Sanuwave Health Expects Q2 Revenue Range $8.5M - $9.5M

Sanuwave Health, Inc. (the "Company" or "Sanuwave") (NASDAQ:SNWV), a leading provider of FDA-cleared directed energy systems used in advanced wound care, today announced that revenues for the second quarter of 2026

Benzinga Newsdesk

PRO
SANUWAVE Health Sees Q2 Sales $11.100M-$11.600M

SANUWAVE Health (NASDAQ:SNWV) sees Q2 sales of $11.100 million-$11.600 million.

Benzinga Newsdesk